Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Nikolaus, de Gregorio"'
Autor:
Dhanya Ramachandran, Jonathan P. Tyrer, Stefan Kommoss, Anna DeFazio, Marjorie J. Riggan, AOCS Group, Penelope M. Webb, Peter A. Fasching, Diether Lambrechts, María J. García, Cristina Rodríguez-Antona, Marc T. Goodman, Francesmary Modugno, Kirsten B. Moysich, Beth Y. Karlan, Jenny Lester, Susanne K. Kjaer, Allan Jensen, Estrid Høgdall, Ellen L. Goode, William A. Cliby, Amanika Kumar, Chen Wang, Julie M. Cunningham, Stacey J. Winham, Alvaro N. Monteiro, Joellen M. Schildkraut, Daniel W. Cramer, Kathryn L. Terry, Linda Titus, Line Bjorge, Liv Cecilie Vestrheim Thomsen, OPAL Study Group, Tanja Pejovic, Claus K. Høgdall, Iain A. McNeish, Taymaa May, David G. Huntsman, Jacobus Pfisterer, Ulrich Canzler, Tjoung-Won Park-Simon, Willibald Schröder, Antje Belau, Lars Hanker, Philipp Harter, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Klaus Baumann, Felix Hilpert, Alexander Burges, Boris Winterhoff, Peter Schürmann, Lisa-Marie Speith, Peter Hillemanns, Andrew Berchuck, Sharon E. Johnatty, Susan J. Ramus, Georgia Chenevix-Trench, Paul D. P. Pharoah, Thilo Dörk, Florian Heitz
Publikováno v:
npj Genomic Medicine, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Survival from ovarian cancer depends on the resection status after primary surgery. We performed genome-wide association analyses for resection status of 7705 ovarian cancer patients, including 4954 with high-grade serous carcinoma (HGSOC),
Externí odkaz:
https://doaj.org/article/ac0253f401c44385bb41f701da028a0c
Autor:
Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in pa
Externí odkaz:
https://doaj.org/article/41e6c37d4d19434583b0e8de81ad13a2
Publikováno v:
National Journal of Clinical Anatomy, Vol 9, Iss 1, Pp 12-15 (2020)
Background and Objectives: Tributaries of inferior vena cava (IVC) are not com pletely described. As IVC has a complex developmental origin, variations in the feeding vessels are common. The main objective of this study was to report the occurrence o
Externí odkaz:
https://doaj.org/article/2d05d67a051047d794717dc60616f5d7
Autor:
Tatjana Braun, Amelie De Gregorio, Lisa Baumann, Jochen Steinacker, Wolfgang Janni, Nikolaus De Gregorio
Publikováno v:
The Surgery Journal, Vol 07, Iss 02, Pp e116-e120 (2021)
Splenosis is a rare disease, which is often discovered incidentally years after surgical procedures on the spleen or traumatic splenic lesions. Through injury of the splenic capsule, splenic cells are able to spread and autoimplant in a fashion simil
Externí odkaz:
https://doaj.org/article/de49dd51004e4a7b857593377c19c288
Autor:
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Füssel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars Hanker, Jan Dominik Kuhlmann
Publikováno v:
Clinical Cancer Research. 28:4660-4668
Purpose: The identification of a robust IHC marker to predict the response to antiangiogenic bevacizumab in ovarian cancer is of high clinical interest. VEGF-A, the molecular target of bevacizumab, is expressed as multiple isoforms with pro- or antia
Autor:
Jan Dominik Kuhlmann, Lars Hanker, Antje Belau, Alexander Burges, Willibald Schröder, Marcel Grube, Felix Hilpert, Klaus Baumann, Tjoung-Won Park-Simon, Barbara Schmalfeldt, Nikolaus de Gregorio, Rainer Kimmig, Jalid Sehouli, Florian Heitz, Stefan Kommoss, Andreas du Bois, Theresa Link, Susanne Füssel, Kati Erdmann, Jacobus Pfisterer, Mara Julia Gerber, Pauline Wimberger
Purpose:The identification of a robust IHC marker to predict the response to antiangiogenic bevacizumab in ovarian cancer is of high clinical interest. VEGF-A, the molecular target of bevacizumab, is expressed as multiple isoforms with pro- or antian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c902d0457c9b3e6f80a5c74e2c85cf
https://doi.org/10.1158/1078-0432.c.6532776
https://doi.org/10.1158/1078-0432.c.6532776
Autor:
Jan Dominik Kuhlmann, Lars Hanker, Antje Belau, Alexander Burges, Willibald Schröder, Marcel Grube, Felix Hilpert, Klaus Baumann, Tjoung-Won Park-Simon, Barbara Schmalfeldt, Nikolaus de Gregorio, Rainer Kimmig, Jalid Sehouli, Florian Heitz, Stefan Kommoss, Andreas du Bois, Theresa Link, Susanne Füssel, Kati Erdmann, Jacobus Pfisterer, Mara Julia Gerber, Pauline Wimberger
Supplementary Figure from Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229c884a530284a906ad424da5896063
https://doi.org/10.1158/1078-0432.22488633
https://doi.org/10.1158/1078-0432.22488633
Autor:
Sophie Fuerst, Thomas Blankenstein, Katharina Prieske, Cordula Petersen, Sven Mahner, Linn Woelber, Mareike Bommert, Hans-Georg Strauss, Matthias W. Beckmann, Nikolaus de Gregorio, Peter Hillemanns, Jalid Sehouli, Klaus Baumann, Severine Iborra, Stefanie Corradini, Felix Hilpert, Anna Jaeger, Alexander Mustea, Christine Eulenburg, Atanas Ignatov
Publikováno v:
Gynecologic Oncology, 164(1), 68-75. ACADEMIC PRESS INC ELSEVIER SCIENCE
Background: The impact of adjuvant radiotherapy (RT) to the vulva with regard to prognosis and local recurrence in patients with vulvar squamous cell cancer (VSCC) is poorly described.Patients and methods: In the AGO-CaRE-1 study 1618 patients with p
Autor:
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Patricia Pautier, Ahmed El-Balat, Jean-Emmanuel Kurtz, Ulrich Canzler, Jalid Sehouli, Martin L. Heubner, Andreas D. Hartkopf, Klaus Baumann, Annette Hasenburg, Lars C. Hanker, Antje Belau, Barbara Schmalfeldt, Dominik Denschlag, Tjoung-Won Park-Simon, Frédéric Selle, Christian Jackisch, Alexander Burges, Hans-Joachim Lück, Günter Emons, Werner Meier, Martina Gropp-Meier, Willibald Schröder, Nikolaus de Gregorio, Felix Hilpert, Philipp Harter
PURPOSE To compare standard versus extended duration of bevacizumab treatment in combination with front-line chemotherapy in women with newly diagnosed stage IIB-IV ovarian cancer. METHODS In this multicenter, open-label, randomized phase III trial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c13b29794f39e0be755b18faba7687
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
Autor:
Soo Jin Park, Hee Seung Kim, Günter Emons, Jae-weon Kim, Karin Weide, Nikolaus de Gregorio, Pauline Wimberger, Fabian Trillsch, Boris Gabriel, Dominik Denschlag, Stefan Kommoss, Mustafa Aydogdu, Thomas Papathemelis, Martina Gropp-Meier, Mustafa-Zelal Muallem, Cristin Kühn, Andreas Müller, Matthias Frank, Michael Weigel, Holger Bronger, Björn Lampe, Jörn Rau, Carmen Schade-Brittinger, Philipp Harter
Publikováno v:
Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.